BioCentury
ARTICLE | Clinical News

EndoBarrier: Pivotal trial hold

April 13, 2015 7:00 AM UTC

Last month, FDA placed a clinical hold on enrollment in the double-blind, sham-controlled, U.S. pivotal ENDO trial of EndoBarrier Gastrointestinal Liner due to 4 cases of hepatic abscess among the 325...